Latest News in the pharma Industry

Biopharma News

Sigma-Aldrich enters South Korean biopharma market

Sigma-Aldrich enters South Korean biopharma market

5 Nov 2012

Sigma-Aldrich will provide its pre-formulation services to CrystalGenomics in Seoul.

Read more 
Consistent long-term govt policies 'key' to biopharmaceutical innovation

Consistent long-term govt policies 'key' to biopharmaceutical innovation

5 Nov 2012

A new report has highlighted key factors for the success of biopharmaceutical innovation.

Read more 
Patheon to acquire Banner Pharmacaps

Patheon to acquire Banner Pharmacaps

30 Oct 2012

Patheon is to acquire Banner Pharmacaps for US$255 million, the company has confirmed.

Read more 
Bluebird awarded funding for trials of LentiGlobin

Bluebird awarded funding for trials of LentiGlobin

29 Oct 2012

A gene therapy developer has received funding for trials of its new treatment for beta-thalassmia.

Read more 
Medicine prices 'under control' in the UK

Medicine prices 'under control' in the UK

29 Oct 2012

The cost of medicine in the UK is among the lowest of all developed nations.

Read more 
Biogen Idec sees 6% growth in Q3 2012

Biogen Idec sees 6% growth in Q3 2012

26 Oct 2012

Biogen enjoyed strong results in the third quarter of 2012.

Read more 
Ezose Sciences licences GlycanMap tech in efforts to discover MS biomarkers

Ezose Sciences licences GlycanMap tech in efforts to discover MS biomarkers

26 Oct 2012

GlycanMap will be used in the search of new biomarkers for MS.

Read more 
Industry welcomes consultation on research exceptions

Industry welcomes consultation on research exceptions

26 Oct 2012

The BioIndustry Association has welcomed a consultation on proposals to clarify the legal framework within which researchers operate with regard to intellectual property.

Read more 
Study shows importance of university support for bioscience start-ups

Study shows importance of university support for bioscience start-ups

26 Oct 2012

Read more 
Biopharma trials scheduled for oral antipsychotic BL-1020

Biopharma trials scheduled for oral antipsychotic BL-1020

25 Oct 2012

BioLine has announced plans to conduct an interim analysis of current Phase II and III trials of BL-1020, its orally available GABA-enhanced antipsychotic for treatment of schizophrenia. The analysis will take place in the coming months, with a complet...

Read more 
DSM and Paranta Biosciences sign biologics contract manufacturing agreement

DSM and Paranta Biosciences sign biologics contract manufacturing agreement

25 Oct 2012

DSM will manufacture recombinant human follistatin at its facility in Brisbane.

Read more 
Pfizer to acquire ADHD specialist NextWave

Pfizer to acquire ADHD specialist NextWave

25 Oct 2012

Pfizer has announced its intention to exercise its option to acquire NextWave Pharmaceuticals.

Read more